SyntheticMR AB (publ) develops and markets medical device imaging solutions* designed to enhance efficiency and diagnostic precision in neuroimaging. The company offers a comprehensive product portfolio, including the SyMRI® solution, which measures absolute brain tissue properties and, from a single fast scan, generates multiple contrast-weighted images, performs automated biomarker segmentation, and provides quantitative data, as well as the AI-powered cNeuro® product suite, which supports clinicians in the assessment and management of neurological disorders.

The company is listed on the Spotlight Stock Market in Stockholm and is headquartered in Linköping, Sweden, with an additional office in Tampere, Finland. For more information, visit syntheticmr.com and combinostics.com.

*Regulatory clearances may vary by product and version, and indications for use may differ between countries/regions.